Flow cytometric measurement of circulating endothelial cells: The effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations

被引:59
作者
Shaffer, RG
Greene, S
Arshi, A
Supple, G
Bantly, A
Moore, JS
Mohler, ER
机构
[1] Univ Penn, Sch Med, Div Cardiovasc, Dept Med, Philadelphia, PA USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Flow Cytometry & Cell Sorting Resource Lab, Philadelphia, PA USA
关键词
progenitor cells; peripheral arterial disease; aging; endothelial cell;
D O I
10.1002/cyto.b.20085
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Age and cardiovascular disease status appear to alter numbers and function of circulating endothelial progenitor cells (EPCs). Despite no universal phenotypic definition, numerous studies have implicated progenitors with apparent endothelial potential in local responses to vascular injury and with cardiovascular disease in general. To further define the role of this lineage in peripheral artery disease (PAD), we developed a multiparameter flow cytometry assay to analyze multiple phenotypic definitions of progenitor cells (PCs), EPCs, and mature endothelial cells (ECs) and evaluate effects of age and PAD on baseline levels of each subset. Methods: Blood was collected from young healthy subjects (N = 9, mean age 33 8 years), older healthy subjects (N = 13, mean age 66 +/- 8 years), and older subjects with PAD (N = 15, mean age 69 +/- 8 years). After ammonium chloride lysis, cells were stained and analyzed on a Becton-Dickinson LSR II with a 5-color antibody panel: FITC-anti-CD31, PE-anti-CD146, PE-anti-CD133, PerCP-Cy5.5-anti-CD3, -CD19,-CD33 (lineage panel), PE-Cy7-anti-CD34, and APC-anti-VEGF-R2. Viability was assessed by propidium iodide exclusion, and only viable, low to medium side scatter lineage-negative singlets were analyzed. In some studies, cells were sorted for morphological studies. Subsets were defined as indicated later. Results: Our results, using a comprehensive flow cytometric panel, indicate that CD133+, CD34+, and CD133+/CD34+ PCs are elevated in younger healthy individuals compared to older individuals, both healthy and with PAD. However, the number of EPCs and mature ECs did not significantly differ among the three groups. Assessment of endothelial colony forming units and dual acLDL-lectin staining supported the flow cytometric findings. Conclusions: We describe a comprehensive flow cytometric method to detect circulating mature and progenitor endothelial populations confirmed by conventional morphological and functional assays. Our findings suggest that aging may influence circulating levels of PCs, but not EPCs or ECs; PAD had no effect on baseline levels of any populations investigated. This study provides the basis for evaluating the potential effects of acute stress and therapeutic intervention on circulating progenitor and endothelial populations as a biomarker for cardiovascular status. (c) 2006 International Society for Analytical Cytology.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 27 条
[1]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[2]   Erythropoietin regulates endothelial progenitor cells [J].
Bahlmann, FH ;
de Groot, K ;
Spandau, JM ;
Landry, AL ;
Hertel, B ;
Duckett, T ;
Boehm, SM ;
Menne, J ;
Haller, H ;
Fliser, D .
BLOOD, 2004, 103 (03) :921-926
[3]   Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes [J].
Cherian, S ;
Moore, J ;
Bantly, A ;
Vergilio, JA ;
Klein, P ;
Luger, S ;
Bagg, A .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 64B (01) :9-17
[4]   HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J].
Dimmeler, S ;
Aicher, A ;
Vasa, M ;
Mildner-Rihm, C ;
Adler, K ;
Tiemann, M ;
Rütten, H ;
Fichtlscherer, S ;
Martin, H ;
Zeiher, AM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :391-397
[5]   Impaired progenitor cell activity in age-related endothelial dysfunction [J].
Heiss, C ;
Keymel, S ;
Niesler, U ;
Ziemann, J ;
Kelm, M ;
Kalka, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (09) :1441-1448
[6]   Circulating endothelial progenitor cells, vascular function, and cardiovascular risk [J].
Hill, JM ;
Zalos, G ;
Halcox, JPJ ;
Schenke, WH ;
Waclawiw, MA ;
Quyyumi, AA ;
Finkel, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :593-600
[7]   Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance [J].
Hristov, M ;
Weber, C .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2004, 8 (04) :498-508
[8]   Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells [J].
Ingram, DA ;
Mead, LE ;
Moore, DB ;
Woodard, W ;
Fenoglio, A ;
Yoder, MC .
BLOOD, 2005, 105 (07) :2783-2786
[9]   Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration [J].
Iwaguro, H ;
Yamaguchi, J ;
Kalka, C ;
Murasawa, S ;
Masuda, H ;
Hayashi, S ;
Silver, M ;
Li, T ;
Isner, JM ;
Asahara, T .
CIRCULATION, 2002, 105 (06) :732-738
[10]   Endothelial progenitor cells [J].
Khakoo, AY ;
Finkel, T .
ANNUAL REVIEW OF MEDICINE, 2005, 56 :79-101